Differential Effects of Human P301L Tau Expression in Young versus Aged Mice
The greatest risk factor for developing Alzheimer’s disease (AD) is increasing age. Understanding the changes that occur in aging that make an aged brain more susceptible to developing AD could result in novel therapeutic targets. In order to better understand these changes, the current study utiliz...
Guardado en:
Autores principales: | Holly C. Hunsberger, Sharay E. Setti, Carolyn C. Rudy, Daniel S. Weitzner, Jeremiah C. Pfitzer, Kelli L. McDonald, Hao Hong, Subhrajit Bhattacharya, Vishnu Suppiramaniam, Miranda N. Reed |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/306c2dc9b1e94039b58557d8c900c0bd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231
por: Sherif Bayoumy, et al.
Publicado: (2021) -
Clioquinol Decreases Levels of Phosphorylated, Truncated, and Oligomerized Tau Protein
por: Gaoping Lin, et al.
Publicado: (2021) -
NMR Studies of Tau Protein in Tauopathies
por: Kristine Kitoka, et al.
Publicado: (2021) -
Amyloid-Driven Tau Accumulation on Mitochondria Potentially Leads to Cognitive Deterioration in Alzheimer’s Disease
por: Mar Cuadrado-Tejedor, et al.
Publicado: (2021) -
Simple, Single-Shot Phosphoproteomic Analysis of Heat-Stable Tau Identifies Age-Related Changes in pS235- and pS396-Tau Levels in Non-human Primates
por: Shannon N. Leslie, et al.
Publicado: (2021)